{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T23:53:11Z","timestamp":1775260391948,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.nmd.2022.12.006","type":"journal-article","created":{"date-parts":[[2022,12,14]],"date-time":"2022-12-14T11:25:31Z","timestamp":1671017131000},"page":"111-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["260th ENMC International Workshop: Congenital myasthenic syndromes 11-13 March 2022, Hoofddorp, The Netherlands"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9579-3514","authenticated-orcid":false,"given":"Sally","family":"Spendiff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro M","family":"Rodr\u00edguez Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Beeson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanns","family":"Lochm\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nmd.2022.12.006_bib0001","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s13023-018-0955-7","article-title":"A nomenclature and classification for the congenital myasthenic syndromes: preparing for FAIR data in the genomic era","volume":"13","author":"Thompson","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nmd.2022.12.006_bib0002","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.nmd.2017.11.013","article-title":"Congenital myasthenic syndromes in Turkey: clinical clues and prognosis with long term follow-up","volume":"28","author":"Durmus","year":"2018","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2022.12.006_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2020.560860","article-title":"Long term follow-up on pediatric cases with congenital myasthenic syndromes-a retrospective single centre cohort study","volume":"14","author":"Della Marina","year":"2020","journal-title":"Front Hum Neurosci"},{"key":"10.1016\/j.nmd.2022.12.006_bib0004","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.nmd.2017.08.003","article-title":"Molecular characterization of congenital myasthenic syndromes in Spain","volume":"27","author":"Natera-de Benito","year":"2017","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2022.12.006_bib0005","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1002\/humu.22130","article-title":"Congenital myasthenic syndromes: achievements and limitations of phenotype-guided gene-after-gene sequencing in diagnostic practice: a study of 680 patients","volume":"33","author":"Abicht","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2022.12.006_bib0006","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/brain\/awz107","article-title":"The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations","volume":"142","author":"Rodr\u00edguez Cruz","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2022.12.006_bib0007","doi-asserted-by":"crossref","first-page":"fcaa174","DOI":"10.1093\/braincomms\/fcaa174","article-title":"Congenital myasthenic syndrome due to a TOR1AIP1 mutation: a new disease pathway for impaired synaptic transmission","volume":"2","author":"Cossins","year":"2020","journal-title":"Brain Commun"},{"key":"10.1016\/j.nmd.2022.12.006_bib0008","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1474-4422(14)70201-7","article-title":"Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment","volume":"14","author":"Engel","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2022.12.006_bib0009","doi-asserted-by":"crossref","first-page":"E1677","DOI":"10.3390\/ijms19061677","article-title":"The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes","volume":"19","author":"Rodr\u00edguez Cruz","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.nmd.2022.12.006_bib0010","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/mus.26676","article-title":"Trouble at the junction: when myopathy and myasthenia overlap","volume":"60","author":"Nicolau","year":"2019","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2022.12.006_bib0011","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.nmd.2014.07.005","article-title":"Congenital myopathies with secondary neuromuscular transmission defects; A case report and review of the literature","volume":"24","author":"Rodr\u00edguez Cruz","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2022.12.006_bib0012","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/brain\/89.1.121","article-title":"Familial limb-girdle myasthenia","volume":"89","author":"McQuillen","year":"1966","journal-title":"Brain"},{"key":"10.1016\/j.nmd.2022.12.006_bib0013","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1136\/jnnp-2016-313163","article-title":"Clinical features of the myasthenic syndrome arising from mutations in GMPPB","volume":"87","author":"Rodr\u00edguez Cruz","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.nmd.2022.12.006_bib0014","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1002\/ajmg.a.61765","article-title":"Biallelic loss of function variants in SYT2 cause a treatable congenital onset presynaptic myasthenic syndrome","volume":"182","author":"Donkervoort","year":"2020","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.nmd.2022.12.006_bib0015","series-title":"GeneReviews\u00ae","article-title":"Congenital myasthenic syndromes overview","author":"Abicht","year":"1993"},{"key":"10.1016\/j.nmd.2022.12.006_bib0016","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.ajhg.2012.09.019","article-title":"Defective presynaptic choline transport underlies hereditary motor neuropathy","volume":"91","author":"Barwick","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2022.12.006_bib0017","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ajhg.2014.08.007","article-title":"Synaptotagmin 2 mutations cause an autosomal-dominant form of lambert-eaton myasthenic syndrome and nonprogressive motor neuropathy","volume":"95","author":"Herrmann","year":"2014","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2022.12.006_bib0018","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.ajhg.2013.03.009","article-title":"Deficiency in SLC25A1, encoding the mitochondrial citrate carrier, causes combined d-2- and l-2-hydroxyglutaric aciduria","volume":"92","author":"Nota","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2022.12.006_bib0019","first-page":"717","article-title":"The RD-Connect Genome-Phenome Analysis Platform: accelerating diagnosis, research, and gene discovery for rare diseases","volume":"43","author":"Laurie","year":"2022","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2022.12.006_bib0020","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/humu.22858","article-title":"The Matchmaker Exchange: a platform for rare disease gene discovery","volume":"36","author":"Philippakis","year":"2015","journal-title":"Hum Mutat"},{"key":"10.1016\/j.nmd.2022.12.006_bib0021","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.nmd.2014.03.005","article-title":"200th ENMC international workshop \u201cEuropean reference networks: recommendations and criteria in the neuromuscular field\u201d, 18-20 October 2013, Naarden, The Netherlands","volume":"24","author":"Evangelista","year":"2014","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.nmd.2022.12.006_bib0022","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3233\/JND-200538","article-title":"The Canadian neuromuscular disease registry 2010-2019: a decade of facilitating clinical research througha nationwide, pan-neuromuscular disease registry","volume":"8","author":"Hodgkinson","year":"2021","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.nmd.2022.12.006_bib0023","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/mus.22140","article-title":"MG Composite and MG-QOL15 Study Group. MG-ADL: still a relevant outcome measure","volume":"44","author":"Muppidi","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2022.12.006_bib0024","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1212\/WNL.0b013e3181dc1b1e","article-title":"MG Composite and MG-QOL15 Study Group. The MG Composite: a valid and reliable outcome measure for myasthenia gravis","volume":"74","author":"Burns","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2022.12.006_bib0025","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/archdischild-2013-304788","article-title":"How common is childhood myasthenia? The UK incidence and prevalence of autoimmune and congenital myasthenia","volume":"99","author":"Parr","year":"2014","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.nmd.2022.12.006_bib0026","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41586-021-03672-3","article-title":"Mechanism of disease and therapeutic rescue of Dok7 congenital myasthenia","volume":"595","author":"Oury","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.nmd.2022.12.006_bib0027","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ajhg.2011.01.008","article-title":"Hexosamine biosynthetic pathway mutations cause neuromuscular transmission defect","volume":"88","author":"Senderek","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.nmd.2022.12.006_bib0028","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1093\/hmg\/ddy225","article-title":"GFPT1 deficiency in muscle leads to myasthenia and myopathy in mice","volume":"27","author":"Issop","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2022.12.006_bib0029","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1126\/science.1250744","article-title":"Neuromuscular disease. DOK7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction","volume":"345","author":"Arimura","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.nmd.2022.12.006_bib0030","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1093\/hmg\/ddaa116","article-title":"Effect of salbutamol on neuromuscular junction function and structure in a mouse model of DOK7 congenital myasthenia","volume":"29","author":"Webster","year":"2020","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.nmd.2022.12.006_bib0031","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1089\/hum.2020.259","article-title":"The platform vector gene therapies project: increasing the efficiency of adeno-associated virus gene therapy clinical trial startup","volume":"31","author":"Brooks","year":"2020","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.nmd.2022.12.006_bib0032","doi-asserted-by":"crossref","first-page":"e88739","DOI":"10.1371\/journal.pone.0088739","article-title":"Injection of a soluble fragment of neural agrin (NT-1654) considerably improves the muscle pathology caused by the disassembly of the neuromuscular junction","volume":"9","author":"Hettwer","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nmd.2022.12.006_bib0033","doi-asserted-by":"crossref","first-page":"E848","DOI":"10.3390\/cells8080848","article-title":"Modulation of agrin and RhoA pathways ameliorates movement defects and synapse morphology in MYO9A-Depleted Zebrafish","volume":"8","author":"O'Connor","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.nmd.2022.12.006_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.594220","article-title":"Modulation of the acetylcholine receptor clustering pathway improves neuromuscular junction structure and muscle strength in a mouse model of congenital myasthenic syndrome","volume":"13","author":"Spendiff","year":"2020","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.nmd.2022.12.006_bib0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.3389\/fneur.2019.00257","article-title":"The Electrophysiology of Presynaptic Congenital Myasthenic Syndromes With and Without Facilitation: from Electrodiagnostic Findings to Molecular Mechanisms","volume":"10","author":"Nicolau","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.nmd.2022.12.006_bib0036","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/nyas.13520","article-title":"Clinical and research strategies for limb-girdle congenital myasthenic syndromes: limb-girdle congenital myasthenic syndromes","volume":"1412","author":"O'Connor","year":"2018","journal-title":"Ann NY Acad Sci"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896622007301?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896622007301?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:13:28Z","timestamp":1760775208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896622007301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":36,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0960896622007301"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2022.12.006","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"260th ENMC International Workshop: Congenital myasthenic syndromes 11-13 March 2022, Hoofddorp, The Netherlands","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2022.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}